(Q43890039)

27 November 2017

title

Role of endocavitary brachytherapy with or without chemotherapy in cancer of the nasopharynx (English)

1 reference

27 November 2017

1 reference

1 reference

Peter C Levendag

1

1 reference

27 November 2017

Frank J Lagerwaard

2

1 reference

27 November 2017

Inge Noever

3

1 reference

27 November 2017

Connie dePan

4

1 reference

27 November 2017

Arent vanNimwegen

5

1 reference

27 November 2017

Oda Wijers

6

1 reference

27 November 2017

Paul I M Schmitz

7

1 reference

27 November 2017

Erik van Dieren

8

1 reference

27 November 2017

Peter J C M Nowak

9

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

International Journal of Radiation Oncology Biology Physics

27 November 2017

published in

1 reference

27 November 2017

volume

52

1 reference

27 November 2017

issue

3

1 reference

27 November 2017

page(s)

755-768

1 reference

Intracavitary brachytherapy significantly enhances local control of early T-stage nasopharyngeal carcinoma: the existence of a dose-tumor-control relationship above conventional tumoricidal dose.

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Brachytherapy for primary and recurrent nasopharyngeal carcinoma: 20 years' experience at Long Beach Memorial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

The role of brachytherapy in early-stage nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Improved local control of nasopharyngeal carcinoma after intracavitary brachytherapy boost

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Analysis of failures after definitive irradiation for epidermoid carcinoma of the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Patterns of failure in carcinoma of the nasopharynx: I. Failure at the primary site

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Megavoltage irradiation of epithelial tumors of the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Effect of time, dose and fractionation on local control of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

The effect of loco-regional control on distant metastatic dissemination in carcinoma of the nasopharynx: an analysis of 1301 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Fractionated high-dose-rate brachytherapy in primary carcinoma of the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Radiation-induced bilateral optic neuropathy in cancer of the nasopharynx. Case failure analysis and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Radionecrosis of the temporal lobe: dynamic susceptibility contrast MRI

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Uncommon otological manifestations of nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Temporal lobe and hypothalamic-pituitary dysfunctions after radiotherapy for nasopharyngeal carcinoma: a distinct clinical syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

A three-dimensional CT-based target definition for elective irradiation of the neck

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

A simplified CT-based definition of the lymph node levels in the node negative neck

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

A new applicator design for endocavitary brachytherapy of cancer in the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Prognostic factors of nasopharynx tumors investigated by MR imaging and the value of MR imaging in the newly published TNM staging.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Chemo-radiotherapy in patients with locally advanced nasopharyngeal carcinoma: a radiation therapy oncology group study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Improved outcome secondary to concurrent chemoradiotherapy for advanced carcinoma of the nasopharynx: preliminary corroboration of the intergroup experience

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

The role of chemotherapy in the management of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Meta-analysis of chemotherapy in head and neck cancer: individual patient data vs literature data

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

High-dose, high-precision treatment options for boosting cancer of the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Conditions for the equivalence of continuous to pulsed low dose rate brachytherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Pulsed dose rate and fractionated high dose rate brachytherapy: choice of brachytherapy schedules to replace low dose rate treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Dose, fractionation and overall treatment time in radiation therapy--the effects on local control for cancer of the larynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Applying radiobiological principles to combined modality treatment of head and neck cancer--the time factor

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Why shorter half-times of repair lead to greater damage in pulsed brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Fractionated high-dose-rate and pulsed-dose-rate brachytherapy: first clinical experience in squamous cell carcinoma of the tonsillar fossa and soft palate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Comparison of three-dimensional conformal radiation therapy and intensity-modulated radiation therapy systems

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: assessment of target coverage and noninvolved tissue sparing

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Stereotactic radiotherapy for locally recurrent nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Results of hypofractionated stereotactic re-irradiation on 13 locally recurrent nasopharyngeal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Fractionated stereotactic radiation therapy for locally recurrent nasopharynx cancer: report of three cases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Radiosurgery for skull base malignancies and nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Intensity modulated therapy and inhomogeneous dose to the tumor: a note of caution

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Nasopharyngeal carcinoma: MRI and CT assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV(> or = N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progr

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal ca

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

Concurrent paclitaxel and radiation in the treatment of locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902719-5

7 January 2021

10.1016/S0360-3016(01)02719-5

Identifiers

DOI

1 reference

27 November 2017

1 reference